FDA Inspection 1207939 — Virginia G. Kaklamani, M.D.

Virginia G. Kaklamani, M.D. — FEI 3026770787

The FDA completed an inspection of Virginia G. Kaklamani, M.D. on May 17, 2023 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 17, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Antonio, TX (United States)

Additional Details

Clinical Investigator (CI)